Financial statements Animal Pharmaceutical Laboratories

Balance sheet of Animal Pharmaceutical Laboratories

Company age:
Age:
15 y. 3 m. 16 d.
Share capital:
Share capital:
60 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of ANIMAL PHARMACEUTICAL LABORATORIES

Year
2018
2019
2020
2021
2022
2023
Total assets 1 009 160,15 4 617 884,61 3 295 827,04 4 023 919,10 3 517 635,92 2 878 698,53
A. Fixed assets 11 953,45 1 775 293,52 847 338,25 807 541,05 774 800,80 753 807,10
B. Current assets 997 206,70 2 842 591,09 2 448 488,79 3 216 378,05 2 742 835,12 2 124 891,43
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 1 009 160,15 4 617 884,61 3 295 827,04 4 023 919,10 3 517 635,92 2 878 698,53
A. Equity 60 000,00 -80 937,93 -74 439,14 -47 018,81 -600 079,75 -1 021 094,66
B. Liabilities and provisions for liabilities 1 165 615,19 4 698 822,54 3 370 266,18 4 070 937,91 4 117 715,67 3 899 793,19
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 1 165 615,19 4 561 322,54 3 097 372,38 3 629 106,12 3 693 587,02 3 492 005,90
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.